Have a personal or library account? Click to login
Punicalagin attenuated allergic airway inflammation via regulating IL4/IL-4Rα/STAT6 and Notch- GATA3 pathways Cover

Punicalagin attenuated allergic airway inflammation via regulating IL4/IL-4Rα/STAT6 and Notch- GATA3 pathways

By: Li Yu and  Jianying Li  
Open Access
|Oct 2022

References

  1. 1. R. Beasley, J. Crane, C. K. Lai and N. Pearce, Prevalence and etiology of asthma, J. Allergy Clin. Immunol. 105(2) (2000) S466-472; https://doi.org/10.1016/s0091-6749(00)90044-7
  2. 2. A. Custovic, S. Marinho and A. Simpson, Gene-environment interactions in the development of asthma and atopy, Expert. Rev. Respir. Med. 6(3) (2012) 301–308; https://doi.org/10.1586/ers.12.24
  3. 3. L. Cohn, J. A. Elias and G. L. Chupp, Asthma: mechanisms of disease persistence and progression, Annu. Rev. Immunol. 22 (2004) 789–815; https://doi.org/10.1146/annurev.immunol.22.012703.104716
  4. 4. D. Y. Kim, J. W. Park, D. Jeoung and J. Y. Ro, Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model, Eur. J. Pharmacol. 612(1-3) (2009) 98–105; https://doi.org/10.1016/j.ejphar.2009.03.078
  5. 5. L. M. Tourangeau, A. Kavanaugh and S. I. Wasserman, The role of monoclonal antibodies in the treatment of severe asthma, Ther. Adv. Respir. Dis. 5(3) (2011) 183–194; https://doi.org/10.1177/1753465811400489
  6. 6. B. J. Lipworth and C. M. Jackson, Safety of inhaled and intranasal corticosteroids: lessons for the new millennium, Drug. Saf. 23(1) (2000) 11–33; https://doi.org/10.2165/00002018-200023010-00002
  7. 7. S. J. Cho, H. W. Kim, B. Y. Kim and S. I. Cho, Sam So Eum, a herb extract, as the remedy for allergen-induced asthma in mice, Pulm. Pharmacol. Ther. 21(3) (2008) 578–583; https://doi.org/10.1016/j.pupt.2008.02.001
  8. 8. L. A. BenSaad, K. H. Kim, C. C. Quah, W. R. Kim and M. Shahimi, Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum, BMC. Complement. Altern. Med. 17(1) (2017) 47; https://doi.org/10.1186/s12906-017-1555-0
  9. 9. F. Danesi, P. A. Kroon, S. Saha, D. de Biase, L. F. D’Antuono and A. Bordoni, Mixed pro- and anti-oxidative effects of pomegranate polyphenols in cultured cells, Int. J. Mol. Sci. 15(11) (2014) 19458–19471; https://doi.org/10.3390/ijms151119458
  10. 10. M. Kraft, C. Lewis, D. Pham and H. W. Chu, IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma, J. Allergy. Clin. Immunol. 107(4) (2001) 602–606; https://doi.org/10.1067/mai.2001.113760
  11. 11. G. Garcia, C. Taille, P. Laveneziana, A. Bourdin, P. Chanez and M. Humbert, Anti-interleukin-5 therapy in severe asthma, Eur. Respir. Rev. 22(129) (2013) 251–257; https://doi.org/10.1183/09059180.00004013
  12. 12. A. Munitz, E. B. Brandt, M. Mingler, F. D. Finkelman and M. E. Rothenberg, Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis, Proc. Natl. Acad. Sci. U. S. A. 105(20) (2008) 7240–7245; https://doi.org/10.1073/pnas.0802465105
  13. 13. M. M. Epstein, Targeting memory Th2 cells for the treatment of allergic asthma, Pharmacol. Ther. 109(1-2) (2006) 107–136; https://doi.org/10.1016/j.pharmthera.2005.06.006
  14. 14. C. E. Brightling, F. A. Symon, S. T. Holgate, A. J. Wardlaw, I. D. Pavord and P. Bradding, Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma, Clin. Exp. Allergy 33(12) (2003) 1711–1716; https://doi.org/10.1111/j.1365-2222.2003.01827.x
  15. 15. G. K. Hershey, IL-13 receptors and signaling pathways: an evolving web, J. Allergy Clin. Immunol. 111(4) (2003) 677–690; https://doi.org/10.1067/mai.2003.1333
  16. 16. A. Hoshino, T. Tsuji, J. Matsuzaki, T. Jinushi, S. Ashino, T. Teramura, K. Chamoto, Y. Tanaka, Y. Asakura, T. Sakurai, Y. Mita, A. Takaoka, S. Nakaike, T. Takeshima, H. Ikeda and T. Nishimura, STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation, Int. Immunol. 16(10) (2004) 1497–1505; https://doi.org/10.1093/intimm/dxh151
  17. 17. D. Amsen, A. Antov, D. Jankovic, A. Sher, F. Radtke, A. Souabni, M. Busslinger, B. McCright, T. Gridley and R. A. Flavell, Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch, Immunity 27(1) (2007) 89–99; https://doi.org/10.1016/j.immuni.2007.05.021
  18. 18. R. Lim, M. J. Zavou, P. Milton, S. T. Chan, J. L. Tan, H. Dickinson, S. V. Murphy, G. Jenkin and E. M. Wallace, Measuring respiratory function in mice using unrestrained whole-body plethysmography, J. Vis. Exp. 90 (2014) e51755; https://doi.org/10.3791/51755
  19. 19. A. R. Schoell, B. R. Heyde, D. E. Weir, P. Chiang, Y. Hu and D. K. Tung, Euthanasia method for mice in rapid time-course pulmonary pharmacokinetic studies, J. Am. Assoc. Lab. Anim. Sci. 48(5) (2009) 506–511.
  20. 20. D. H. Broide, M. Lotz, A. J. Cuomo, D. A. Coburn, E. C. Federman and S. I. Wasserman, Cytokines in symptomatic asthma airways, J. Allergy. Clin. Immunol. 89(5) (1992) 958–67; https://doi.org/10.1016/0091-6749(92)90218-q
  21. 21. S. E. Wenzel, Asthma: defining of the persistent adult phenotypes, Lancet 368(9537) (2006) 804–813; https://doi.org/10.1016/S0140-6736(06)69290-8
  22. 22. A. J. Wardlaw, C. Brightling, R. Green, G. Woltmann and I. Pavord, Eosinophils in asthma and other allergic diseases, Br. Med. Bull. 56(4) (2000) 985–1003; https://doi.org/10.1258/0007142001903490
  23. 23. J. Bousquet, P. K. Jeffery, W. W. Busse, M. Johnson and A. M. Vignola, Asthma. From bronchoconstriction to airways inflammation and remodeling, Am. J. Respir. Crit. Care Med. 161(5) (2000) 1720–1745; https://doi.org/10.1164/ajrccm.161.5.9903102
  24. 24. C. Bachert, N. Zhang, G. Holtappels, L. De Lobel, P. van Cauwenberge, S. Liu, P. Lin, J. Bousquet and K. Van Steen, Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma, J. Allergy. Clin. Immunol. 126(5) (2010) 962–968; https://doi.org/10.1016/j.jaci.2010.07.007
  25. 25. S. J. Szabo, S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman and L. H. Glimcher, A novel transcription factor, T-bet, directs Th1 lineage commitment, Cell 100(6) (2000) 655–669; https://doi.org/10.1016/s0092-8674(00)80702-3
  26. 26. K. A. Mowen and L. H. Glimcher, Signaling pathways in Th2 development, Immunol. Rev. 202 (2004) 203–222; https://doi.org/10.1111/j.0105-2896.2004.00209.x
  27. 27. Y. Y. Wan, GATA3: a master of many trades in immune regulation, Trends. Immunol. 35(6) (2014) 233–242; https://doi.org/10.1016/j.it.2014.04.002
DOI: https://doi.org/10.2478/acph-2022-0038 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 561 - 573
Accepted on: May 11, 2022
Published on: Oct 18, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2022 Li Yu, Jianying Li, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.